C. Michael Stein

9.5k citations

68 papers · 7.0k indexed · 3 hit papers · h-index 36

Impact in

Pharmacology top 0.1%
- Pharmacogenetics and Drug Metabolism
Rheumatology top 0.5%
- Systemic Lupus Erythematosus Research
- Rheumatoid Arthritis Research and Therapies

Papers in

Rheumatology 27
- Systemic Lupus Erythematosus Research 17
- Rheumatoid Arthritis Research and Therapies 17
Pharmacology 13
- Pharmacogenetics and Drug Metabolism 12

Co-authors: Cecilia P. Chung Richard B. Kim Wayne A. Ray Ayumi Shintani Annette Oeser Paolo Raggi Katherine T. Murray Kathi Hall
Journals: New England Journal of Medicine (5 papers)Arthritis Care & Research (4 papers)Pharmacogenetics and Genomics (4 papers)Circulation (3 papers)The Journal of Rheumatology (3 papers)
Partner nations: United States Finland Israel

In The Last Decade

C. Michael Stein

67 papers receiving 6.8k citations

Hit Papers

align trajectories log scale

Drugs That May Cause or Exacerbate Heart Failure 2016 · 324 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2016 Circulation
2009 New England Journal of Medicine
2003 New England Journal of Medicine

Peers

Countries citing papers authored by C. Michael Stein

Since Specialization

Citations

This map shows the geographic impact of C. Michael Stein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Michael Stein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Michael Stein more than expected).

Fields of papers citing papers by C. Michael Stein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Michael Stein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Michael Stein. The network helps show where C. Michael Stein may publish in the future.

Co-authorship network

The 25 scholars most cited alongside C. Michael Stein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with C. Michael Stein Line = papers co-authored together C. Michael Stein links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta‐Blocker Therapy Clinical Pharmacology & Therapeutics ·Julio D. Duarte, Cameron D. Thomas, Craig R. Lee, Rachel Huddart, José A. G. Agúndez, Inês Valente Lopes, Andrea Gaedigk, Teri E. Klein, David E. Lanfear, Andrew A. Monte, Mohamed Nagy, Matthias Schwab, C. Michael Stein, Chakradhara Rao S. Uppugunduri, Ron H. N. van Schaik, R. Kawalla, Kelly E. Caudle, Jasmine A. Luzum	2024	22
2	Association between urinary sodium and potassium excretion and blood pressure and inflammation in patients with rheumatoid arthritis Clinical Rheumatology ·郁朗高木, Chengxiang Wan, Michelle J. Ormseth, Annette Oeser, Joseph F. Solus, Xiaoyan Zhang, Raúl Nozal González, Jens Titze, C. Michael Stein, Cecilia P. Chung	2017	6
3	Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing Data Archiving and Networked Services (DANS) ·Kelly A. Birdwell, Brian S. Decker, Julia M. Barbarino, Josh F. Peterson, C. Michael Stein, Wolfgang Sadée, Daqing Wang, Alexander A. Vinks, Yijing He, Jesse J. Swen, J. Steven Leeder, RHN van Schaik, Kenneth E. Thummel, Teri E. Klein, Kelly E. Caudle, Iain MacPhee	2015	63
4	High-density lipoprotein function in rheumatoid arthritis Current Opinion in Lipidology ·Michelle J. Ormseth, C. Michael Stein	2015	19
5	Genetics of serum concentration of IL-6 and TNFα in systemic lupus erythematosus and rheumatoid arthritis: a candidate gene analysis Clinical Rheumatology ·Joseph F. Solus, Cecilia P. Chung, Annette Oeser, Chun Li, Young Hee Rho, Kevin M. Bradley, Vivian K. Kawai, Jeffrey R. Smith, C. Michael Stein	2015	51
6	Urinary Albumin Excretion Is Increased in Patients with Rheumatoid Arthritis and Associated with Arterial Stiffness The Journal of Rheumatology ·Eliane Aparecida Bollis, Annette Oeser, Michelle J. Ormseth, Joseph F. Solus, Paolo Raggi, C. Michael Stein, Cecilia P. Chung	2015	14
7	Effect of the VKORC1 D36Y variant on warfarin dose requirement and pharmacogenetic dose prediction Thrombosis and Haemostasis ·Jose Welmowicki, Dorte Bodin Desbrøll, Aharon Lubetsky, Noa Markovits, Chun Li, C. Michael Stein, Hillel Halkin, Eva Gak, Ronen Loebstein, Daniel Kurnik	2012	16
8	Changes in cotherapies after initiation of disease‐modifying antirheumatic drug therapy in patients with rheumatoid arthritis Arthritis Care & Research ·Vivian K. Kawai, Carlos G. Grijalva, Patrick G. Arbogast, Jeffrey R. Curtis, Daniel H. Solomon, Elizabeth Delzell, Lang Chen, Rita Ouellet‐Hellstrom, Lisa J. Herrinton, Liyan Liu, Edward F. Mitchel, C. Michael Stein, Marie R. Griffin	2011	20
9	Cystatin C, Renal Function, and Atherosclerosis in Rheumatoid Arthritis The Journal of Rheumatology ·G. Dorado, Aihua Bian, Young Hee Rho, Vivian K. Kawai, Paolo Raggi, Annette Oeser, Joseph F. Solus, Tebeb Gebretsadik, Ayumi Shintani, C. Michael Stein	2011	18
10	ACCF/AHA Clopidogrel Clinical Alert: Approaches to the FDA “Boxed Warning” Journal of the American College of Cardiology ·David R. Holmes, Gregory Dehmer, Sanjay Kaul, Dana Leifer, Patrick T. O’Gara, C. Michael Stein	2010	258
11	Adipocytokines, insulin resistance, and coronary atherosclerosis in rheumatoid arthritis Arthritis & Rheumatism ·Young Hee Rho, Cecilia P. Chung, Joseph F. Solus, Paolo Raggi, Annette Oeser, Tebeb Gebretsadik, Ayumi Shintani, C. Michael Stein	2010	46
12	Role of inflammation and oxidative stress in atrial fibrillation Heart Rhythm ·Jie Li, Joseph F. Solus, Qingxia Chen, Young Hee Rho, Ginger L. Milne, C. Michael Stein, Dawood Darbar	2009	249
13	The α2C-adrenoceptor deletion322–325 variant and cold-induced vasoconstriction Clinical Autonomic Research ·Eitan Friedman, Paul A. Harris, Alastair J.J. Wood, C. Michael Stein, Daniel Kurnik	2009	4
14	Amino‐terminal fragment of the prohormone brain‐type natriuretic peptide in rheumatoid arthritis Arthritis & Rheumatism ·Joseph F. Solus, Cecilia P. Chung, Annette Oeser, Ingrid Avalos, Tebeb Gebretsadik, Ayumi Shintani, Paolo Raggi, Tuulikki Sokka, Theodore Pincus, C. Michael Stein	2008	48
15	Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis Atherosclerosis ·Cecilia P. Chung, Annette Oeser, Joseph F. Solus, Ingrid Avalos, Tebeb Gebretsadik, Ayumi Shintani, Paolo Raggi, Tuulikki Sokka, Theodore Pincus, C. Michael Stein	2007	272
16	Genetic Variability in CYP3A5 and its Possible Consequences Pharmacogenomics ·L. M. Aroyo, Alastair J.J. Wood, Richard B. Kim, C. Michael Stein, G. Wilkinson	2004	230
17	Premature Coronary-Artery Atherosclerosis in Systemic Lupus Erythematosus New England Journal of Medicine ·Yu Asanuma, Annette Oeser, Ayumi Shintani, Elizabeth Turner, Nancy J. Olsen, Sergio Fazio, MacRae F. Linton, Paolo Raggi, C. Michael Stein Hit paper breakdown →	2003	646
18	Educational Program for Nursing Home Physicians and Staff to Reduce Use of Non-Steroidal Anti-Inflammatory Drugs Among Nursing Home Residents Medical Care ·C. Michael Stein, Marie R. Griffin, Jo Taylor, James W. Pichert, Kenneth D. Brandt, Wayne A. Ray	2001	66
19	Combination treatment of severe rheumatoid arthritis with cyclosporine and methotrexate for forty‐eight weeks. An open‐label extension study Arthritis & Rheumatism ·C. Michael Stein, Theodore Pincus, David E. Yocum, Peter Tugwell, 김홍갑, Oscar Gluck, G Kraag, З. Я. Надашкевич, John Tesser, R J McKendry, Raye H. Brooks, (unknown)	1997	65
20	Arthritis associated with HIV infection in Zimbabwe. PubMed ·C. Michael Stein, Paul Davis	1996	35

About C. Michael Stein

C. Michael Stein is a scholar working on Rheumatology, Pharmacology, Cardiology and Cardiovascular Medicine, Biochemistry and Toxicology, having authored 68 papers that have together received 7.0k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (17 papers), Rheumatoid Arthritis Research and Therapies (17 papers), Pharmacogenetics and Drug Metabolism (12 papers), Heart Rate Variability and Autonomic Control (7 papers), Drug Transport and Resistance Mechanisms (7 papers), Hormonal Regulation and Hypertension (6 papers), Atherosclerosis and Cardiovascular Diseases (6 papers) and Eicosanoids and Hypertension Pharmacology (5 papers). The work is most often cited by research in Pharmacology (1.6k citations), Rheumatology (1.7k citations), Cardiology and Cardiovascular Medicine (2.1k citations), Internal Medicine (182 citations) and Geriatrics and Gerontology (185 citations). C. Michael Stein has collaborated with scholars based in United States, Finland and Israel. Frequent co-authors include Cecilia P. Chung, Richard B. Kim, Wayne A. Ray, Ayumi Shintani, Annette Oeser, Paolo Raggi, Katherine T. Murray, Kathi Hall, Alastair J.J. Wood and Joseph F. Solus. Their work appears in journals such as New England Journal of Medicine, Arthritis Care & Research, Pharmacogenetics and Genomics, Circulation and The Journal of Rheumatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact